Nebivolol Sandoz

Nebivolol, the active ingredient in Nebivolol Sandoz, is a beta blocker (selective β1-adrenergic antagonist) presented as a tablet for oral use. It is used to treat hypertension and certain forms of heart failure in adult patients. GNH USA supplies Nebivolol Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist indicated for cardiovascular conditions that benefit from beta‑blockade.

Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. Heart failure (NYHA class II‑III): improves symptoms and functional capacity in patients with reduced ejection fraction. Chronic stable heart failure: helps to manage long‑term heart failure symptoms and may reduce hospitalisation.

Nebivolol may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: general tiredness or lack of energy. - Bradycardia: slower than normal heart rate. - Nausea: feeling of queasiness or urge to vomit. - Peripheral edema: swelling of the lower limbs.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - Bronchospasm: narrowing of airways, particularly in asthmatic patients. - Heart block: impaired electrical conduction in the heart. - Allergic reactions: rash, itching, or swelling. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before prescribing Nebivolol, clinicians should evaluate patient‑specific factors and monitor for potential risks.

Cardiovascular assessment: check baseline heart rate and blood pressure. Renal impairment: adjust therapy if significant kidney dysfunction is present. Asthma or COPD: use with caution due to possible bronchoconstriction. Concomitant medications: review for interactions that may enhance bradycardia or hypotension. Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): increased risk of AV block. - Clonidine abrupt withdrawal: rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may cause excessive blood pressure lowering. - Diuretics: potential electrolyte disturbances and volume depletion. - Antidiabetic agents: may mask hypoglycemia symptoms.